These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 1169340)

  • 1. [Effect of somatostatin on in vitro pituitary superfusion system in rats].
    Sawano S; Kokubu T; Isizuka Y
    Nihon Rinsho; 1975 Mar; 33(3):567-71. PubMed ID: 1169340
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
    Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J
    Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin, and thyrotropin.
    Maeda K; Frohman LA
    Endocrinology; 1978 Nov; 103(5):1903-9. PubMed ID: 107023
    [No Abstract]   [Full Text] [Related]  

  • 5. Pituitary actions of somatostatin.
    Snow MH; Scanlon MF; Mora B; Heath M; Hall R; Gomez-Pan A
    Ann Clin Res; 1978; 10(3):145-50. PubMed ID: 214011
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium modifies the effects of thyroliberin and somatostatin on hormone release from cell cultures of the rat anterior pituitary.
    Komolov IS; Fedotov VP; Gudoshnikov VI; Fazekas I; Rappay G
    Endokrinologie; 1982 Nov; 80(3):318-24. PubMed ID: 6131817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secretory control of pituitary hormones--growth hormone and prolactin].
    Takeda S; Togane T; Inoue K; Irie M
    Nihon Rinsho; 1986 Mar; 44(3):587-92. PubMed ID: 2874246
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
    Kagabu Y; Mishiba T; Okino T; Yanagisawa T
    Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effect of potassium and calcium ion on the release of growth hormone and prolactin from isolated rat pituitaries in vitro.
    Wakabayashi I; Arimura A; Schally AV
    Endokrinologie; 1972 Jan; 59(1):69-76. PubMed ID: 5032187
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 11. Pituitary effects of somatostatin.
    Hall R; Snow M; Scanlon M; Mora B; Gomez-Pan A
    Metabolism; 1978 Sep; 27(9 Suppl 1):1257-62. PubMed ID: 210355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of an enkephalin analog on the endocrine system in man].
    Földes J; Váradi A; Gara A; Bános C; Székely J; Török K; Varga P
    Orv Hetil; 1985 May; 126(19):1145-8. PubMed ID: 4011214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Effect of somatostatine on plasma STH in acromegalic patients (author's transl)].
    Milhaud G; Ribeiro F; Rivaille P
    Ann Endocrinol (Paris); 1974; 35(6):671-3. PubMed ID: 4463816
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone.
    Brazeau P; Vale W; Rivier J; Guillemin R
    Life Sci; 1974 Jul; 15(2):351-7. PubMed ID: 4549923
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium modification of the somatostatin effect on stimulated rat growth hormone release.
    Stachura ME
    Endocrinology; 1981 Mar; 108(3):1027-34. PubMed ID: 6109624
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of somatostatin on the concentration of growth hormone in the plasma of foetal sheep.
    McMillen IC; Jenkin G; Thorburn GD; Robinson JS
    J Endocrinol; 1978 Sep; 78(3):453-4. PubMed ID: 712304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebral amines and pituitary function].
    Imura H; Kato Y; Chihara K; Taigo K; Nakai Y
    Horumon To Rinsho; 1973 Oct; 21(10):997-1005. PubMed ID: 4797012
    [No Abstract]   [Full Text] [Related]  

  • 18. Enkephalin-stimulated prolactin release.
    Lien EL; Fenichel RL; Garsky V; Sarantakis D; Grant NH
    Life Sci; 1976 Sep; 19(6):837-40. PubMed ID: 966966
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of in vivo administration of somatostatin on cell-free protein synthesis of pituitary and of adrenal ribosomes.
    Tragl KH; Kinast H; Steininger H; Geyer G
    Metabolism; 1978 Sep; 27(9 Suppl 1):1387-90. PubMed ID: 683007
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of somatostatin receptor subtypes in mammalian pituitary.
    Epelbaum J; Briard N; Djordjijevic D; Dutour A; Meyerhoff W; Oliver C; Slama A; Viollet C; Zhang J
    Ann N Y Acad Sci; 1998 May; 839():249-53. PubMed ID: 9629161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.